Tag: evenity market trends

Backed by market attractiveness analysis, total addressable market sizing, company benchmarking matrices, interactive Excel dashboards, wider supply chain intelligence, emerging startup coverage, and detailed product-level insights, The Business Research Company’s 2026 market reports are designed to offer research that is more actionable and strategically valuable than ever.

Evenity Market Size Forecast: How Big Could The Market Get By 2030?

The expansion observed historically stems from an aging female demographic, the widespread occurrence of postmenopausal osteoporosis, shortcomings of antiresorptive medications, a rise in fracture-related illness, and the initial positive results of biologic bone treatments.

The anticipated expansion during the forecast period is linked to increased understanding of bone health, more widespread osteoporosis screenings, the broader application of biologics, improved healthcare accessibility for senior populations, and supportive reimbursement policies for preventing fractures. Key trends throughout this period are expected to include a surge in the use of anabolic osteoporosis therapies, an intensified focus on reducing fracture risk, a growing preference for monthly injectable treatments, short-duration high-efficacy osteoporosis regimens, and the integration of biologic therapies within bone health management.

Get A Free Sample Report With In-Depth Market Insights:

https://thebusinessresearchcompany.com/sample_request?id=74762355&type=smp&name=Evenity%20Market%20Report%202026&utm_source=Blogs&utm_medium=Paid&utm_campaign=Oct_PR

Evenity Market Growth Drivers: What’s Behind The Acceleration?

The Evenity market is anticipated to expand as the occurrence of osteoporosis becomes more widespread. Osteoporosis is a medical condition marked by a reduction in bone density and quality, rendering bones weaker and more susceptible to fractures. This increase in osteoporosis cases is attributed to an aging demographic experiencing a natural decline in bone density, alongside sedentary lifestyles that diminish skeletal strength. Evenity is administered monthly, for a maximum of 12 months, to treat osteoporosis by stimulating bone formation, decreasing bone breakdown, and reinforcing bones to avert fractures. For instance, in February 2023, the Royal Osteoporosis Society, a UK based charity, presented written evidence estimating that fragility fractures incur an annual cost of $5.89billion (£4.5 billion) for the NHS, with hip fractures alone accounting for $2.62 billion (£2 billion) of this total. Consequently, the rising prevalence of osteoporosis is stimulating growth in the Evenity market.

Evenity Market Segment Analysis: What Are The Core Market Categories?

The evenity market covered in this report is segmented –

1) By Indication: Postmenopausal Osteoporosis, Osteoporosis In Men

2) By Distribution Channel: Hospital Pharmacies, Retail Pharmacies, Online Pharmacies

3) By End User: Hospitals And Clinics, Specialty Centers, Homecare Settings, Research And Academic Institutions

Evenity Market Top Companies Driving Competitive Growth

Major companies operating in the evenity market are Amgen Inc., UCB S.A

View The Full Evenity Market Report:

https://thebusinessresearchcompany.com/report/evenity-global-market-report?utm_source=Blogs&utm_medium=Paid&utm_campaign=Oct_PR

Evenity Market Leading Geography: Which Region Contributes The Most Revenue?

North America was the largest region in the evenity market in 2025. Europe is expected to be the fastest-growing region in the forecast period. The regions covered in the evenity market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Reach Out To Our Team:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas: +1 310-496-7795

Asia: +44 7882 955267 & +91 8897263534

Europe: +44 7882 955267

Email us at: marketing@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

Delivering more actionable and strategically valuable research, The Business Research Company’s 2026 market reports feature market attractiveness analysis, total addressable market evaluation, company benchmarking matrices, interactive Excel dashboards, expanded supply chain intelligence, emerging startup coverage, and detailed product insights.

Evenity Market Size And Revenue Forecast Through 2030

The expansion observed during the historic period was driven by several key factors, including an aging female demographic, a widespread occurrence of postmenopausal osteoporosis, the shortcomings associated with antiresorptive medications, elevated rates of fracture-linked morbidity, and the initial positive outcomes from biologic bone treatments.

The forecast period’s expansion is driven by heightened awareness of bone health, a surge in osteoporosis screenings, broader application of biologics, improved healthcare availability for older adults, and favorable reimbursement policies for fracture prevention. Key developments expected include the increased adoption of anabolic osteoporosis treatments, a stronger emphasis on minimizing fracture risks, a shift toward monthly injectable options, short-term osteoporosis regimens with high effectiveness, and the incorporation of biologic therapies into bone health management.

Download A Free Sample Report For Comprehensive Market Insights:

https://www.thebusinessresearchcompany.com/sample.aspx?id=20067&type=smp&utm_source=BlogsPR&utm_medium=Paid&utm_campaign=Jul_PR

Evenity Market Development Factors: Which Trends Are Supporting Demand?

The growing occurrence of osteoporosis is anticipated to fuel the evenity market’s expansion moving forward. Osteoporosis is a health issue marked by reduced bone density and quality, causing bones to become fragile and more susceptible to fractures. This rising prevalence stems from an aging population experiencing natural bone density loss and inactive lifestyles that compromise skeletal strength. Administered as a monthly injection for up to 12 months, evenity treats osteoporosis by enhancing bone formation, curbing bone resorption, and fortifying bones to prevent fractures. For example, in February 2023, the Royal Osteoporosis Society, a UK-based charity, submitted written evidence indicating that fragility fractures cost the NHS $5.89 billion (£4.5 billion) each year, with hip fractures alone representing $2.62 billion (£2 billion) of this expense. Consequently, the increasing prevalence of osteoporosis is propelling the evenity market’s growth.

A rise in drug approvals is forecasted to boost the evenity market in upcoming years. Drug approvals refer to the formal assessment and authorization of pharmaceutical drugs by regulatory bodies for public use. This increase is mainly driven by biotechnological progress that accelerates drug discovery and supportive regulatory measures, like expedited approval programs, that simplify processes for medications in high demand. These approvals aid evenity growth by broadening the range of innovative therapies available, improving patient access, and building trust among healthcare professionals. For instance, in July 2024, the American Society of Gene and Cell Therapy (ASGCT), a US-based professional body, reported that in the second quarter of 2024, 76 gene therapy trials were launched, a 25% rise from the prior quarter. Hence, the growing number of drug approvals is driving the evenity market’s expansion.

Higher healthcare spending is expected to fuel the evenity market’s growth going forward. Healthcare expenditure encompasses all financial resources dedicated to medical services, preventive care, medications, and health-related pursuits aimed at improving or preserving population health. This spending is climbing due to increased medical needs from an aging populace and technological innovations that raise treatment expenses. Funds for evenity are directed toward covering drug costs, strengthening healthcare infrastructure, and improving osteoporosis treatment access, especially for older groups. For example, in May 2024, the Office for National Statistics, a UK government agency, noted that total healthcare expenditure grew by 5.6% in nominal terms from 2022 to 2023, a notable acceleration from the 0.9% rise seen in 2022. Therefore, rising healthcare expenditure is propelling the evenity market’s growth.

Evenity Market Segments: Where Are The Largest Growth Opportunities?

The evenity market covered in this report is segmented –

1) By Indication: Postmenopausal Osteoporosis, Osteoporosis In Men

2) By Distribution Channel: Hospital Pharmacies, Retail Pharmacies, Online Pharmacies

3) By End User: Hospitals And Clinics, Specialty Centers, Homecare Settings, Research And Academic Institutions

Evenity Market Major Participants And Competitive Dynamics

Major companies operating in the evenity market are Amgen Inc., UCB S.A

Access The Complete Evenity Market Report:

https://www.thebusinessresearchcompany.com/report/evenity-global-market-report?utm_source=BlogsPR&utm_medium=Paid&utm_campaign=Jul_PR

Evenity Market Largest Region: Which Geography Holds The Highest Market Share?

North America was the largest region in the evenity market in 2025. Europe is expected to be the fastest-growing region in the forecast period. The regions covered in the evenity market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/?utm_source=BlogsPR&utm_medium=Paid&utm_campaign=home_page_test

Americas: +1 310-496-7795

Asia: +44 7882 955267 & +91 8897263534

Europe: +44 7882 955267

Email us at: marketing@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

The Business Research Company’s 2026 market reports feature advanced enhancements such as market attractiveness analysis, total addressable market evaluation, company benchmarking matrices, interactive Excel dashboards, expanded supply chain intelligence, emerging startup coverage, and detailed product insights, delivering more actionable and strategically valuable research.

What Market Value Expansion Is Expected For The Evenity Market Over The Forecast Period?

The expansion observed during this historical timeframe stemmed from an increasing elderly female population, the widespread occurrence of osteoporosis in postmenopausal women, the inherent limitations of antiresorptive medications, a rise in morbidity associated with fractures, and the initial positive results from biologic bone therapies.

The anticipated market expansion throughout the forecast period is fueled by an escalating understanding of bone wellness, a rise in osteoporosis diagnostic procedures, the broadening application of biologics, improved healthcare accessibility for older demographics, and favorable reimbursement structures for preventing fractures.

Prominent trends expected during the projection period involve an increasing utilization of anabolic osteoporosis treatments, a sharpened focus on minimizing fracture risk, a growing inclination towards monthly injectable therapies, the development of short-duration yet highly effective osteoporosis regimens, and the integration of biologic treatments into comprehensive bone health strategies.

Download A Free Sample Report For Comprehensive Market Insights:

https://www.thebusinessresearchcompany.com/sample.aspx?id=20067&type=smp

Which Strategic Drivers Are Supporting The Evenity Market Development?

The growing incidence of osteoporosis is projected to boost the expansion of the evenity market in the coming period. Osteoporosis is a health condition marked by a decline in bone density and quality, resulting in fragile bones highly susceptible to fractures. The increasing prevalence of osteoporosis is attributed to an aging demographic experiencing a natural reduction in bone density and inactive lifestyles that diminish skeletal strength. Evenity is administered monthly via injection for up to 12 months to address osteoporosis by fostering bone formation, minimizing bone resorption, and reinforcing bones to prevent breaks. For example, in February 2023, the Royal Osteoporosis Society, a UK-based charity, presented written evidence estimating that fragility fractures incur an annual cost of $5.89billion (£4.5 billion) for the NHS, with hip fractures alone accounting for $2.62 billion (£2 billion) of this expense. Consequently, the rising occurrence of osteoporosis is propelling the growth of the evenity market.

Evenity Market Driver: Increasing Drug Approvals Drive Growth In The Market

How Is The Evenity Market Examined Through Segment Analysis?

The evenity market covered in this report is segmented –

1) By Indication: Postmenopausal Osteoporosis, Osteoporosis In Men

2) By Distribution Channel: Hospital Pharmacies, Retail Pharmacies, Online Pharmacies

3) By End User: Hospitals And Clinics, Specialty Centers, Homecare Settings, Research And Academic Institutions

Which Companies Are Engaged In The Evenity Market Environment?

Major companies operating in the evenity market are Amgen Inc., UCB S.A

Access The Complete Evenity Market Report:

https://www.thebusinessresearchcompany.com/report/evenity-global-market-report

Which Region Holds The Largest Share In The Evenity Market?

North America was the largest region in the evenity market in 2025. Europe is expected to be the fastest-growing region in the forecast period. The regions covered in the evenity market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas: +1 310-496-7795

Asia: +44 7882 955267 & +91 8897263534

Europe: +44 7882 955267

Email us at: marketing@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

The Business Research Company’s 2026 market reports include new capabilities such as market attractiveness scoring and analysis, total addressable market analysis, company scoring matrix, interactive excel data dashboard, improved supply chain analysis, upcoming startups in the market, and overview of key products, aimed at improving the depth, usability, and strategic value of the insights delivered.

What Market Size Increase Is Anticipated For The Evenity Market Over The 2026–2030 Period?

The growth experienced in the historical timeframe can be linked to an expanding elderly female demographic, the widespread occurrence of postmenopausal osteoporosis, the inherent limitations of antiresorptive medications, a rise in morbidity associated with fractures, and the promising initial achievements of biologic bone therapies.

Anticipated growth during the forecast period is driven by enhanced public understanding of bone wellness, a rise in osteoporosis diagnostic procedures, wider adoption of biologic treatments, improved healthcare accessibility for senior demographics, and favorable reimbursement policies supporting fracture avoidance.

Key trends identified for the forecast period encompass the increasing application of anabolic therapies for osteoporosis, an intensified emphasis on minimizing fracture probabilities, a leaning towards injectable treatments administered on a monthly basis, the adoption of highly effective, brief osteoporosis treatment plans, and the incorporation of biologic treatments into overall bone health management.

Download the Free Sample Report to Explore Key Market Insights:

https://www.thebusinessresearchcompany.com/sample.aspx?id=20067&type=smp

What Underlying Factors Are Accelerating The Growth Of The Evenity Market?

The growing incidence of osteoporosis is projected to stimulate the expansion of the Evenity market in the future. Osteoporosis is a medical condition defined by a reduction in bone density and quality, leading to weakened bones more susceptible to fractures. The increasing occurrence of osteoporosis is fueled by an aging population experiencing a natural decline in bone density and inactive lifestyles that diminish skeletal strength. Evenity is administered as a monthly injection for a duration of up to 12 months to address osteoporosis by promoting bone formation, decreasing bone breakdown, and reinforcing bones to prevent fractures. For example, in February 2023, the Royal Osteoporosis Society, a UK-based charity, submitted written evidence estimating that fragility fractures cost the NHS $5.89 billion (£4.5 billion) annually, with hip fractures alone accounting for $2.62 billion (£2 billion) of that total. Therefore, the rising prevalence of osteoporosis is propelling the growth of the Evenity market.

Evenity Market Driver: Increasing Drug Approvals Drive Growth In The Market

How Is The Evenity Market Segmented Across Key Categories?

The evenity market covered in this report is segmented –

1) By Indication: Postmenopausal Osteoporosis, Osteoporosis In Men

2) By Distribution Channel: Hospital Pharmacies, Retail Pharmacies, Online Pharmacies

3) By End User: Hospitals And Clinics, Specialty Centers, Homecare Settings, Research And Academic Institutions

Who Are The Dominant Players Shaping The Evenity Market Landscape?

Major companies operating in the evenity market are Amgen Inc., UCB S.A

Read the full evenity market report here:

https://www.thebusinessresearchcompany.com/report/evenity-global-market-report

Which Region Is Projected To Dominate The Evenity Market During The Forecast Period?

North America was the largest region in the evenity market in 2025. Europe is expected to be the fastest-growing region in the forecast period. The regions covered in the evenity market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Request A Tailored Evenity Market Research Report For Competitive Advantage:

https://www.thebusinessresearchcompany.com/customise?id=20067&type=smp

Browse Through More Reports Similar to the Global Evenity Market 2026, By The Business Research Company

Alternative Finance Market Report 2026

https://www.thebusinessresearchcompany.com/report/alternative-finance-global-market-report

Data Lake Market Report 2026

https://www.thebusinessresearchcompany.com/report/data-lake-global-market-report

Trade Finance Market Report 2026

https://www.thebusinessresearchcompany.com/report/trade-finance-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795

Asia +44 7882 955267 & +91 8897263534

Europe +44 7882 955267

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

Uncover key drivers, emerging technologies, and competitive movements shaping the evenity market from 2026–2035 with trusted insights from The Business Research Company

How much is the Evenity Market valued at in 2026, and what valuation is forecast for 2030?

The expansion witnessed during the historical period is primarily due to several factors, including a growing elderly female population, the widespread occurrence of postmenopausal osteoporosis, the inherent limitations of antiresorptive medications, an increase in fracture-related illness, and the initial promising results of biologic bone therapies.

The anticipated growth during the forecast period is attributable to an increasing understanding of bone well-being, a rise in osteoporosis screenings, the expanded application of biologics, greater healthcare access for older populations, and supportive reimbursement schemes for fracture prevention. Significant trends expected in this timeframe include the growing utilization of anabolic osteoporosis treatments, a heightened emphasis on reducing fracture risks, a preference for monthly injectable therapies, short-duration yet highly effective osteoporosis regimens, and the integration of biologic treatments into bone health management.

Access Your Free Sample Report for In-Depth Market Insights:

https://www.thebusinessresearchcompany.com/sample.aspx?id=20067&type=smp

What Drivers Are Influencing The Growth Of The Evenity Market?

The growing incidence of osteoporosis is anticipated to stimulate the expansion of the evenity market moving forward. This medical condition is defined by a decline in bone density and quality, leading to bones that are weaker and more susceptible to fractures. The increasing occurrence of osteoporosis is fueled by an aging population, which naturally experiences decreasing bone density, and sedentary lifestyles that compromise skeletal strength. Evenity is administered as a monthly injection for a duration of up to 12 months, treating osteoporosis by boosting bone formation, diminishing bone resorption, and strengthening bones to prevent fractures. For instance, in February 2023, the Royal Osteoporosis Society, a UK-based charity, submitted written evidence estimating that fragility fractures cost the NHS $5.89billion (£4.5 billion) annually, with hip fractures alone accounting for $2.62 billion (£2 billion) of that total. Consequently, the rising prevalence of osteoporosis is propelling the growth of the evenity market.

How Is The Evenity Market Organized Into Various Segments?

The evenity market covered in this report is segmented –

1) By Indication: Postmenopausal Osteoporosis, Osteoporosis In Men

2) By Distribution Channel: Hospital Pharmacies, Retail Pharmacies, Online Pharmacies

3) By End User: Hospitals And Clinics, Specialty Centers, Homecare Settings, Research And Academic Institutions

Who Are The Primary Competitors In The Global Evenity Market?

Major companies operating in the evenity market are Amgen Inc., UCB S.A

Access The Complete Report For Deeper Market Insights:

https://www.thebusinessresearchcompany.com/report/evenity-global-market-report

Which Global Regions Are Shaping The Competitive Landscape Of The Evenity Market?

North America was the largest region in the evenity market in 2025. Europe is expected to be the fastest-growing region in the forecast period. The regions covered in the evenity market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Request Your Customized Evenity Market Research Report for Competitive Advantage:

https://www.thebusinessresearchcompany.com/customise?id=20067&type=smp

Browse Through More Reports Similar to the Global Evenity Market 2026, By The Business Research Company

Alternative Finance Market Report 2026

https://www.thebusinessresearchcompany.com/report/alternative-finance-global-market-report

Data Lake Market Report 2026

https://www.thebusinessresearchcompany.com/report/data-lake-global-market-report

Trade Finance Market Report 2026

https://www.thebusinessresearchcompany.com/report/trade-finance-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795

Asia +44 7882 955267 & +91 8897263534

Europe +44 7882 955267

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

Claim your 30% discount on Global Market Reports with code ONLINE30. Limited time only.

How Has The Evenity Market Size Shifted, And What Is the Outlook Through 2034?

In recent years, the size of the evenity market has experienced a XX (HCAGR) rise. Its expansion from $XX million in 2024 to $XX million in 2025 infers a compound annual growth rate (CAGR) of XX%. The surge during this historical phase can be traced back to a greater understanding of osteoporosis and measures to prevent fractures, the need for biologic drugs, a rising aged population, better diagnostic capabilities, and demand for products related to bone health.

How Much Will the Evenity Market Be Worth in 2029?

Over the coming years, the evenity market size is projected to reach a notable CAGR of XX%. By 2029, its value is predicted to rise to a sizable $XX million, all thanks to an XX% annual compound growth rate. The expansion in the forecast period is majorly due to the increasing endorsement of biologics and sophisticated injectables, the growing incidence of osteoporosis, higher prevalence of chronic kidney disease (CKD), a rise in the occurrence of rheumatoid arthritis, and an upsurge in the number of co-existing medical conditions. The forecast period will witness significant trends including innovations in delivery mechanisms, integration of digital health provisions, increased reliance on biosimilars, pioneering therapies and major advancements in the field of diagnostics.

Download The Free Sample Report Here:

https://www.thebusinessresearchcompany.com/sample.aspx?id=20067&type=smp

Which is the Largest Company in the Evenity Market?

Major companies operating in the evenity market include Amgen Inc.; UCB S.A

What Are the Main Market Drivers in the Evenity Industry?

The escalating incidence of osteoporosis is anticipated to boost the evenity market’s expansion in the future. Known for its characteristics of reduced bone density and quality, osteoporosis essentially leads to more fragile bones that are susceptible to fractures. The spike in osteoporosis incidence is attributed to an aging population suffering from a natural drop in bone density and inactive lifestyles which impair skeletal robustness. Evenity is utilized as a regular monthly injection over a course of 12 months to address osteoporosis, enhancing bone creation, minimizing bone absorption, and fortifying bones to avert fractures. To illustrate, the report published by the UK Parliament in October 2022 indicated that osteoporotic fractures are currently costing the NHS beyond $5.8 billion (£4.6 billion), a number that may potentially touch roughly $7.5 billion (£6 billion) by 2030 due to an older population. Consequently, the rising incidence of osteoporosis is fuelling the progression of the evenity market.

Request For A Customized Report:

https://www.thebusinessresearchcompany.com/customise?id=20067&type=smp

How Is the Evenity Market Segments Structured?

The evenity market covered in this report is segmented –

1) By Indication: Postmenopausal Osteoporosis, Osteoporosis In Men

2) By Distribution Channel: Hospital Pharmacies, Retail Pharmacies, Online Pharmacies

3) By End User: Hospitals And Clinics, Specialty Centers, Homecare Settings, Research And Academic Institutions

Access The Full Report Here:

https://www.thebusinessresearchcompany.com/report/evenity-global-market-report

Which Global Regions Offer the Highest Growth in the Evenity Market?

North America was the largest region in the evenity market in 2024. Europe is expected to be the fastest-growing region in the forecast period. The regions covered in the evenity market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.

Purchase The Full Report Today:

https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=20067

This Report Delivers Insight On:

1. How big is the evenity market, and how is it changing globally?

2. Who are the major companies in the evenity market, and how are they performing?

3. What are the key opportunities and risks in the evenity market right now?

4. Which products or customer segments are growing the most in the evenity market?

5. What factors are helping or slowing down the growth of the evenity market?

About The Business Research Company:

With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795

Asia +44 2071930708

Europe +44 7882 955267

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

2025 Market Reports Update: Market Size Forecasts to 2034, Key Trends, Leading Players, and Top Regions – Get Ahead of the Competition Today!

What Major Innovations Are Driving the Accelerated Growth of the Evenity Market?

The increasing prevalence of osteoporosis is expected to drive the growth of the Evenity market. Osteoporosis is a condition where bones become weak and fragile. The rising prevalence of osteoporosis is linked to aging and sedentary lifestyles. Evenity is a monthly injection that increases bone formation and reduces bone resorption to prevent fractures. The UK Parliament reported in October 2022 that osteoporotic fractures cost the NHS over $5.8 billion annually, with costs expected to rise. The increasing prevalence of osteoporosis will drive the Evenity market.

Get Your Free Sample Report Now – Explore Exclusive Market Insights:

https://www.thebusinessresearchcompany.com/sample.aspx?id=20067&type=smp

#What is the Growth Potential of the Evenity Market, and How Will It Perform by 2034?

The evenity market has grown at XX (HCAGR). It will increase from $XX million in 2024 to $XX million in 2025 at a CAGR of XX%. Drivers included osteoporosis awareness, biologics demand, aging populations, improved diagnostics, and demand for bone health solutions.

The evenity market size is expected to grow at XX (FCAGR) in the next few years, reaching $XX million by 2029, with a CAGR of XX%. Growth is attributed to biologics acceptance, rising osteoporosis prevalence, chronic kidney disease, rheumatoid arthritis, and comorbidity increases. Trends include innovations in delivery systems, digital health tools, biosimilars adoption, innovative therapies, and diagnostic advancements.

You can Directly Purchase the Report Here:

https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=20067

What Are the Top Market Players Propelling the Growth of theEvenity Industry?

Major companies operating in the evenity market include Amgen Inc.; UCB S.A

Order Your Report Now For A Swift Delivery:

https://www.thebusinessresearchcompany.com/report/evenity-global-market-report

Which Primary Segments of the Evenity Market Are Driving Growth and Industry Transformations?

The evenity market covered in this report is segmented –

1) By Indication: Postmenopausal Osteoporosis, Osteoporosis In Men

2) By Distribution Channel: Hospital Pharmacies, Retail Pharmacies, Online Pharmacies

3) By End User: Hospitals And Clinics, Specialty Centers, Homecare Settings, Research And Academic Institutions

Gain Exclusive Market Insights—Customize Your Research Report Today for Fast Delivery!

https://www.thebusinessresearchcompany.com/customise?id=20067&type=smp

Which Regions Are Key Players in the Growth of the #What Major Innovations Are Driving the Accelerated Growth of the Evenity Market?# Market?

North America was the largest region in the evenity market in 2024. Europe is expected to be the fastest-growing region in the forecast period. The regions covered in the evenity market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.

Browse Through More Reports Similar to the Global Evenity Market 2025, By The Business Research Company:

Osteoporosis Treatment Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/osteoporosis-treatment-global-market-report

Postmenopausal Osteoporosis Treatment Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/postmenopausal-osteoporosis-treatment-global-market-report

Osteoporosis Drugs Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/osteoporosis-drugs-global-market-report

About The Business Research Company:

With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.

Contact us at:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 3156230293

Asia +44 2071930708

Europe +44 2071930708

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

Found this article helpful? Share it on: